Background/Aims: Myocardial ischemia/reperfusion injury is a major cause of morbidity and mortality associated with coronary heart disease. Many studies have demonstrated that natural products are promising chemotherapeutic drugs counteracting the loss of cardiomyocytes. Thus, the purpose of the present study was to investigate the effects of geniposide, a traditional Chinese herb extract from Gardenia jasminoides J. Ellis, on cardiomyocyte apoptosis induced by hypoxia/reoxygenation (H/R) in H9c2 cells, and their underlying mechanisms. Methods: Cell viability and apoptosis ratio were assessed using the cell counting kit-8 assay and Annexin V/propidium iodide (PI) staining. The concentrations of lactate dehydrogenase (LDH), intracellular total superoxide dismutase (T-SOD), and malondialdehyde (MDA) were detected by microplate reader. The production of reactive oxygen species/reactive nitrogen species (ROS/RNS), the level of mitochondrial calcium, and mitochondrial membrane potential depolarization were measured by confocal laser scanning microscopy. Mitochondrial morphology was visualized using transmission electron microscopy. The expressions of Bcl-2 mRNA and Caspase-3 mRNA were measured by reverse transcription-polymerase chain reaction (RT-PCR). The protein levels of cleaved caspase-3, Bcl-2, Bax, AKT, p-AKT serine473 , cytochrome-c were detected by western bloting. Results: Geniposide pretreatment increased cell viability, decreased LDH levels in the supernatant, and inhibited cardiomyocyte apoptosis caused by H/R. Furthermore, geniposide reversed mitochondrial dysfunction by decreasing oxidative stress products (ROS/RNS and MDA), increasing anti-oxidative enzyme (T-SOD) level, improving mitochondrial morphology, attenuating mitochondrial calcium overload and blunting depolarization of mitochondrial membrane. Moreover, geniposide pretreatment increased Bcl-2 level and decreased Bax level, thus enhancing the Bcl-2/Bax ratio. Consistent
Introduction
Currently, ischemia heart disease is an overwhelming health burden worldwide [1, 2] . Cardiomyocyte apoptosis caused by ischemia/reperfusion (I/R) injury can lead to myocardial cell loss, which further accelerates cardiac dysfunction, ventricular remodeling, and even heart failure [3] [4] [5] [6] . Numerous studies have reported that inhibition of apoptosis could attenuate myocardial damage, decrease cardiomyocyte removal, and improve ventricular contractile function caused by I/R [7] . Cardiomyocyte apoptosis includes two major pathways, the extrinsic pathway via death receptors, and the intrinsic pathway involving mitochondria [8, 9] . Notably, the mitochondria-dependent pathway plays a key role in I/R-induced myocardial cell apoptosis [3, 4, 10] . The most typical characteristic of myocardial ischemia is severe hypoxia, which could cause acidosis, energy depletion, and ion homeostasis rupture, ultimately resulting in cardiomyocyte death [11] . Mitochondria are abundant in myocardial cells and are responsible for energy metabolism by utilizing oxygen, and they are undoubtedly involved in the pathophysiological changes that occur during I/R injury. Successful reperfusion, is absolutely necessary to reduce the infarct area of the heart. However, reperfusion also generates abundant products of oxidative stress, such as reactive oxygen species/reactive nitrogen species (ROS/RNS), which could trigger mitochondrial oxidative stress, mitochondrial calcium overload, and mitochondrial membrane depolarization, leading to opening of the mitochondrial permeability transition pore (mPTP), release of large pro-apoptosis proteins, cardiomyocyte apoptosis, and death [8, [12] [13] [14] . Therefore, inhibition of mitochondrial oxidative stress during the I/R process might be a key therapeutic approach.
Gardenia jasminoides J. Ellis, a kind of traditional Chinese herb, has extensive pharmacological actions in the treatment of inflammation, hepatic disorders and hypertension. Geniposide, an extract of Gardenia jasminoides J. Ellis and a novel agonist for glucagon-like peptide-1 receptor (GLP-1R), has been shown to exert antinociception effects [15] , promote β-cell regeneration, attenuate β-cell apoptosis [16, 17] , regulate insulin secretion in INS-1 cells [18] , and prevent oxidative stress of PC12 cell [19] . Accumulating evidences has revealed that glucagon-like peptide 1 (GLP-1) and GLP-1 analogues exert anti-apoptotic effects by activating GLP-1R via the phosphatidylinositol 3 kinase (PI3K)/ AKT signaling pathway [3, [20] [21] [22] . Geniposide can also activate GLP-1R in response to oxidative stress in PC12 cells via the PI3K/AKT pathway [23] , inhibit PC12 cell death by the mitochondrial pathway [24] , and attenuate memory deficits in amyloid precursor protein (APP)/ presenilin 1(PS1) transgenic mice by improving mitochondrial dysfunction [25] . Nevertheless, the effects of geniposide on the cardiovascular system are poorly understood.
To mimic myocardial I/R injury, we established a hypoxia/reoxygenation (H/R) model in H9c2 cells. In this study, we investigated the protective effect of geniposide in cardiomyocytes against H/R-induced apoptosis, and whether the mechanism involved improving mitochondrial dysfunction, and activating GLP-1R and PI3K/AKT pathway. To detect T-SOD levels, the cell lysis buffers were incubated with reagents of the T-SOD kit at 37°C for 20 min, T-SOD value was examined at 450 nm using a microplate reader and are expressed as U/(mg protein).
To detect MDA, the cell lysis buffers were incubated with reagents of the MDA assay kit and boiled at 95°C for 40 min, MDA value was determined at 530 nm and are expressed as nmol/(mg prot). LDH level were measure six times. T-SOD and MDA detection was repeated three times.
Transmission electron microscope
The cells (6 × 10 5 ) were planted in culture bottles. After grown 70-80%, each group of cells was cultured in the relevant treatment. Cells were washed, digested, centrifugalized, collected, and then fixed by 2.5% glutaraldehyde (Shanghai Junrui Biological Technology Co. Ltd, Shanghai, China) for 2h. After washing three times with cold PBS, each group of cells was fixed with 1% osmium tetroxide (Shanghai Junrui Biological Technology Co. Ltd) for 15min. Next, each group of cells were embedded in EPON812 (Shanghai Easy Micro Mdt InfoTech Ltd, Shanghai, China) following dehydration in an ascending series of acetone (50% acetone for 10 min, 70% acetone for 10 min, 90% acetone for 10 min, and 100% acetone for 10 min). Finally, the specimens were cut into 1 μm sections, and the sections were stained with sodium acetate (Shanghai Junrui Biological Technology Co. Ltd) and lead citrate (Beijing Economy Instruments Science & Technology Co. Beijing, China). Ultrathin sections were examined with a transmission electron microscope (Hitachi-7500, Tokyo Japan). The above experiment was repeated three times.
Confocal laser scanning microscopy ROS/RNS production, mitochondrial calcium concentration and depolarization ratio of mitochondrial membrane potential were measured by confocal laser scanning microscopy (Nikon, A1 + R , Tokyo, Japan) with a 2', 7'-dichlorodihydrofluorescein diacetate (DCFH-DA) probe, a dihydroethidium (DHE) probe, a Rhod-2 AM probe, and a JC-1 probe (all from Beyotime Institute of Biotechnology), respectively. Cell (1 × 10 5 ) were seeded in a confocal dish (cover glass bottom dish) for 24 h under normal conditions, and then preincubated with geniposide for 30 min followed by H/R. After the cultivation mentioned above, the supernatants were discarded, and cells were respectively loaded with DCFH-DA (10 μM), DHE (5 μM), Rhod-2 AM (2 μM), and JC-1 (5 μg/ml) at 37°C for 20 min, 30 min, 30 min, and 25 min. DCFH-DA (green fluorescence) was excited at 488 nm and emitted at 525 nm. DHE (red fluorescence) was excited at 535 nm and emitted at 610 nm. Rhod-2 AM (blue fluorescence) was excited at 543 nm and emitted at 560 nm. JC-1 monomer (green fluorescence) was excited at 514 nm and emitted at 529 nm. JC-1 aggregate (red fluorescence) was excited at 585 nm and emitted at 590 nm. The above experiment was repeated three times.
Cell RNA extraction and real-time reverse transcriptase polymerase chain reaction (RT-PCR)
All reagent kits of real-time RT-PCR were purchased from TaKaRa Biotechnology (Dalian, China). Total RNA was isolated from H9c2 cells using RNAiso Plus, and the concentrations of RNA and cDNA were determined using an ultraviolet spectrophotometer (Olympus, Tokyo, Japan). PrimeScript ® RT reagent Kit was used to synthesize cDNA and the reaction volume (20 µl) contained 4 µl 5×PrimeScript ® Buffer, 1 µl PrimeScript ® RT Enzyme MixΙ, 1µl oligo dT primer, 1µl random 6 mers, 2 µl total RNA, and 11 µl RNase free dH 2 O. Reverse transcription parameters were as follows: 37°C 15 min (reverse transcription reaction) and 85°C 5 sec (decreasing activity of the reverse transcriptase). Then 2 µl cDNA template (50 ng/µl) was reacted with 12.5µl SYBR ® Premix Ex Taq TM II, 1 µl of each primer (10 µM), and 8.5µl dH 2 O using ABI PRISM 7500 real-time PCR system (Applied Biosystems, Foster City, CA, USA). Primers were synthesized by TaKaRa Biotechnology and were as follows: 5' GGAGGAACTCTTCAGGGATGG 3' and 5' AGATGCCGGTTCAGGTACTCAG 3' for Bcl-2; 5' GAACGGACCTGTGGACCTGA 3' and 5' TGAATGATGAAGAGTTTCGGCT 3' for caspase-3. The above experiment was repeated three times.
Mitochondrial and cytosolic protein fractionation
In order to detect the release of cytochrome C from mitochondria to cytosol, mitochondria and cytosol were isolated using the Cell Mitochondria Isolation Kit (Abcam, ab110170, Cambridge, UK). Cells were digested and collected by centrifugation at 800 g for 5 min, frozen and thawed to weaken the membranes, and then resuspended in reagent A (5 mg/ml) on ice for 10 min. The cell suspension was homogenizaed with 30 strokes using a pestle on ice. The homogenate was centrifuged at 800 g for 10 min at 4°C to remove large particles. The supernatant was centrifuged and collected at 12000 g for 30 min at 4°C to isolate the cytosol (suspernatant) and mitochondria (pellet) fractions. Sample protiens of the cytosolic and mitochondrial fractions were extrated using radioimmunoprecipitation assay (RIPA) lysis buffer and reagent C, respectively, and then subjected to western blotting.
Western blot analysis
H9c2 cells of each group were washed with PBS twice, and then mixed with mixed lysate buffer containing phenylmethanesulfonyl fluoride (PMSF) (1:1,000) and RIPA lysis buffer. Cell lysates were collected by centrifugation at 12,000 g for 15 min at 4°C. The supernatant was collected and boiled for 5 min, and then combined with sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) sample loading buffer. The protein concentrations of supernatant were measured using an enhanced BCA protein assay kit. Protein (50 μg) resolved by SDS-PAGE and transferred to PVDF membranes. Membranes were blocked in 5% nonfat milk for 2 h. The membranes were then incubated with primary antibody (anticytochrome-c antibody (1:1500, Abcam, Cambridge, UK), anti-COX IV antibody (1:2,000, Abcam, Cambridge, UK), anti-cleaved caspase-3 antibody, anti-Bax antibody, anti-Bcl-2 antibody, anti-AKT antibody, antiphospho-AKT serine473 (1:1,000, Cell Signaling Technology, Inc., Beverly, MA, USA), and anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody (1:1,000 , Beyotime Institute of Biotechnology)) overnight at 4°C and then incubated with horseradish peroxidase (HRP)-conjugated goat anti-rabbit or HRP-conjugated goat anti-mouse(1:1,000, Beyotime Institute of Biotechnology) at 37°C for 1 h. The signals were detected with the enhanced chemiluminescence (ECL) system (Beyotime Institute of Biotechnology). The bands were scanned by Bio-Rad gel imaging system (Bio-Rad, Hercules, CA, USA) and the results were analyzed with Quantity One software. The above experiment was repeated three times.
Statistical analysis
All statistical analyses were performed using the SPSS 17.0 software (Chicago, IL, USA). Data are presented as mean ± standard deviation (SD) and were analyzed with one-way analysis of variance (ANOVA) or Student-Newman-Keuls test. P<0.05 was considered statistically significant.
Results

Geniposide increased cell viability of H9c2 cells subjected to H/R
Cell viability was tested by CCK-8 assay at diverse time durations of H/R (4/2, 6/3, 12/4, 14/5, 16/6, 22/10 h). Cell viability of H/R groups was lower than that of control group (Fig. 1A ) . With 6/3 h H/R treatment, cell viability was reduced to 80.42% of the control .82%, 48.53%, and 32.36% of the control group, respectively (P < 0.01). Since the 12/4 h H/R was the shortest time point when the difference in cell viability compared to control was statistically significant (P < 0.01), this time point was selected for further study.
The effects of gradient concentrations of geniposide pretreatment on H9c2 cell viability subjected to H/R (12/4h) were observed. We found that geniposide treatment (10, 20, 40, 80 μM for 30 min) reversed the loss of H9c2 cells that were exposed to H/R (Fig. 1B) (P < 0.05). Moreover, the protective effect of geniposide pretreatment on cell viability peaked at concentration 40 μM (P < 0.01).
Geniposide decreased LDH level in H9c2 cells subjected to H/R
The expression of LDH was higher in the H/R group than that in the control group (P < 0.01, Fig. 2 ). Geniposide pretreatment (10, 20, 40 , 80 μM) remarkably reduced the level of LDH (P < 0.05). LDH level in the 40 μM and 80 μM geniposide pretreatment groups were lower than that of 10 μM and 20 μM geniposide pretreatment groups (P < 0.05, Fig. 2 ), but no significant difference was observed between 40 μM geniposide pretreatment group and 80 μM geniposide pretreatment group. Based on CCK-8 results and LDH level, 40 μM of geniposide was considered the optimal concentration for further research. 
Geniposide attenuated H/R-induced H9c2 cell apoptosis ratio
The apoptosis ratio of cells in the H/R group was higher than that of the control group (P < 0.01). However, this ratio could be significantly reduced with pretreatment of geniposide (P < 0.01, Fig. 3 ), indicating that geniposide could exert cardioprotective effects by inbibiting H/R-induced apoptosis of H9c2 cells.
Geniposide reduced H/R-induced oxidative stress in H9c2 cells induced
The production of ROS (P < 0.01) and RNS (P < 0.05) was significantly increased in the H/R group compared with that of the control group. Nonetheless, geniposide pretreatment significantly decreased the production of ROS (P < 0.01) and RNS (P < 0.05) induced by H/R (Fig. 4A and B) .
Intracellular levels of T-SOD and MDA were measured to confirm further the antioxidative ability of geniposide. In the H/R group, the production of MDA was increased dramatically in comparison to that of control group, whereas, T-SOD level was extremely decreased (P < 0.01, Fig. 4C and D) . In contrast, While geniposide pretreatment significantly weakened this increase of MDA (P < 0.05) and decrease of T-SOD (P < 0.01). were analyzed by confocal microscopy analysis software. Values are expressed as mean ± SD. n = 3. *P < 0.05, vs control group. # P < 0.05, vs H/R group.
Geniposide improved mitochondrial morphological changes and reduced mitochondrial calcium overload and the depolarization of mitochondrial membrane potential in H9c2 cells subjected to H/R
In the H/R group, changes in mitochondrial morphology, such as swelling, disorganization, and reduction or vanishing of the crista, were increased compared to the control group. Pretreatmen with 40 μM geniposide, however, improved these mitochondrial morphological changes in H9c2 cells induced by H/R (Fig. 5A ). Mitochondrial calcium ([Ca 2+ ] m ) of the H/R group was distinctly increased compared with that of control group (P < 0.05), while this increase was reversed with 40 μM geniposide pretreatment (P < 0.05) (Fig. 5B) .
Polarized (red) and depolarized (green) mitochondria were detected by confocal laser scanning microscope using the JC-1 probe. The depolarization ratio of ΔΨm was represented by the fluorescence ratio of red to green. Red fluorescence decreased while green fluorescence remarkably increased in the H/R group compared with that of the control group (P < 0.05, Fig. 5C ), showing that H/R downregulated the red to green ratio. This ratio in the geniposide pretreatment group was increased compared to that of the H/R group (P < 0.05).
Geniposide downregulated caspase-3 mRNA expression and upregulated Bcl-2 mRNA expression in H9c2 cells induced by H/R
The RT-PCR results revealed that caspase-3 mRNA expression increased and Bcl-2 mRNA expression decreased significantly after H/R (P < 0.05), while this trend was attenuated by geniposide pretreatment (P < 0.05, Fig. 6 ).
Geniposide inhibited cleaved caspase-3, Cytochrome-c, Bax protein expression and augmented Bcl-2 and p-AKT
serine473 levels As shown in Fig. 7 , protein expression in the H/R group of cleaved caspase-3 (P < 0.01, Fig. 7A ), cytochrome-c (P < 0.05, Fig. 7F and G) and Bax (P < 0.05, Fig. 7B ) was increased while the expression of Bcl-2 (P<0.01, Fig. 7C ) and p-AKT serine473 (P < 0.01, Fig. 7E ) was decreased compared to that of the control group. In comparison, pretreatment with geniposide remarkably decreased protein expression of caspase-3, cytochrome-c, and Bax and increased protein expression of Bcl-2 and p-AKT serine473 , thus enhancing the Bcl-2/Bax ratio (P < 0.05, Fig. 7D) .
In oder to investigate the translocation of cytochrome c from mitochondria into the cytosol, we analyzed the expression level of cytochrome c in the cytosolic and mitochodrial fractions by western blot. As shown in Fig. 7F and G, the level of mitochondrial cytochrome c decreased and the level of cytosolic cytochrome c increased in H/R group compared with those of the control group (P < 0.05). Geniposide treatment, however, reduced the level of cytochrome c released into cytosol (P < 0.05). We did not detect COXIV (a mitochondrial marker) in the cytosol, indicating that the cytosolic fraction was not contaminated with mitochondrial proteins.
Cardioprotection of geniposide involved activation of GLP-1R and the PI3K/AKT signaling pathway
To investigate further the antiapoptotic mechanism of geniposide on H9c2 cells induced by H/R, we determined the effect of GLP-1R antagonist exendin (9-39) and the PI3K inhibitor LY294002 on geniposide cardioprotection. As shown in Fig. 8A , the cell viability of the H/R group was decreased compared with that of the control group (P < 0.01), while, pretreatment with geniposide increased cell viability (P < 0.05). This effect of geniposide was inhibited by LY294002 and exendin (9-39). There was no significant difference in cell viability among the control + E, control + L, Geniposide, and control groups. The apoptosis raito of the H/R group was higher than that of contol group (P < 0.01), which geniposide pretreatment reduced (P < 0.01). Exendin (9-39) and LY294002, however, blocked the effects of geniposide (Fig. 8B) . The differences in the apoptosis ratios of control + E, control + L, Geniposide, and control groups were not significant. Preincubation with geniposide decreased the protein level of cleaved caspase-3 (P < 0.05) and an increased the protein level of P-AKT serine473 (P < 0.05), which were supressed by LY294002 and exendin (Fig. 8C) . Taken together, these findings suggested that the protection of geniposide might be, at least in part, associated with activing the GLP-1R and PI3K/AKT signaling pathway.
Discussion
Our findings revealed that geniposide, a promising cardioprotective natural extractive, could inhibit apoptosis in H9c2 cells apoptosis by improving mitochondrial dysfunction, as demonstrated by improved mitochondrial morphological changes, attenuating mitochondrial oxidative stress, reduced mitochondrial calcium overload, and preservation of mitochondrial membrane potential. This study is the first to demonstrate that anti-apoptotic effects of geniposide regarding mitochondrial function involve GLP-1R, and the PI3K/AKT signaling pathway in H9c2 cells in response to the H/R injury.
Cell viability is an important index to determine cell survival. LDH, one marker of cardiomyocyte injury, leaks out into the blood-stream when the cell membrane becomes [26] . In the present study, geniposide pretreatment mitigated increases in LDH level and increased H9c2 cell viability during H/R, suggesting its protective effects on cardiomyocytes against H/R-caused damage. Cardiomyocyte apoptosis induced by I/R is an essential process in the progression of heart failure. Mitochondria play a crucial role in cardiomyocyte apoptosis under hypoxic conditions [3, 4] . This study showed that H/R treatment caused mitochondrial dysfunction and cardiomyocyte apoptosis, whereas, pretreatment with geniposide improved mitochondrial dysfunction and attenuated mitochondria-dependent cell apoptosis.
In addition to their significant role in cell apoptosis, mitochondria are also the primary sources of oxidative stress during H/R [3, 10] . ROS and RNS are products of mitochondrial oxidative stress, and production of ROS is a vital step in the mitochondria-dependent apoptosis pathway [3, 4, 27] . Physiological levels of ROS/RNS in normal oxidative metabolism play a key homeostatic role in balancing disposal rates of oxidative pressure and enzyme systems in cell proliferation and survival [27] [28] [29] . As levels of SOD, glutathione, and catalase are less in the cardiac system, excessive production of ROS/RNS triggers oxidative stress and aggravates ischemia-induced cardiomyocyte damage [27, 30] , further accelerating cardiomyocyte apoptosis and loss [31, 32] . Treatment with antioxidant agents or upregulation of endogenous antioxidant enzymes could prevent excessive ROS-caused injury [4, 33, 34] . Here, we showed that the generation of ROS and RNS were obviously augmented in the H/R group compared to that in the control group and that, this effect was notably reduced by geniposide pretreatment. Moreover, the oxidative product MDA was clearly decreased and the antioxidant enzyme T-SOD was remarkably increased in the H/R + geniposide group compared with that of H/R group. Therefore, we have shown for the first time that geniposide pretreatment inhibited ROS/RNS and, MDA synthesis and elevated T-SOD levels in H9c2 cells during H/R, resulting in attenuation of mitochondria oxidative stress as an analogous antioxidant.
Mitochondrial oxidative stress triggered by excessive ROS accelerates mitochondria malfunction, decreases energy supply of mitochondria, and destroys calcium homeostasis, leading to mitochondrial calcium overload. This combination of excessive ROS and mitochondrial calcium overload assault mitochondria membranes, nucleic acids, proteins, and lipids, resulting in nuclear DNA degradation. In addition, they open mPTP, increase the depolarization ratio of ΔΨm, rupture the mitochondria outer membrane, promote release of cytochrome-c, and activate cytochrome-c-mediated caspase family, finally leading to cell apoptosis and death [35, 36] . Importantly, consistent with the result of ROS, geniposide pretreatment remarkably decreased [Ca2+]m and the depolarization ratio of ΔΨm and improved mitochondrial morphological changes. Moreover, Lv et al. found that geniposide might attenuate mitochondrial oxidative stress-induced memory deficits by suppressing ROS generation and the augmenting ΔΨm in APP/PS1 mice [25] . In this study, we found that geniposide pretreatment inhibited H/R-caused apoptosis in H9c2 cells by improving mitochondrial dysfunction.
A crucial function of Bcl-2 is to regulate the activation of mitochondrial outer membrane permeability (MOMP) and mPTP, which are the central switch of mitochondria-dependent apoptosis [8] . Bcl-2 inhibits MOMP, while Bax protein activates MOMP. Moreover, apoptosis associated Bcl-2 activation regulates two-way cross-talk between the mitochondria and endoplasmic reticulum (ER) which has an essential role in Ca2+ stores [37] [8, 38] . However, in the present study, geniposide pretreatment increased Bcl-2 protein level and attenuated Bax protein in H/R-treated H9c2 cells, and preserved the ratio of Bcl-2/Bax. In addition, Bcl-2 mRNA expression was enhanced in the H/R + geniposide group. The decrease of Bcl-2/Bax ratio, mitochondria calcium overload, and opening of mPTP further collapsed mitochondria membrane potential and ruptured the outer membrane of mitochondria, finally releasing pro-apoptotic molecules into the cytoplasm [35] . Surprisingly, we found that geniposide not only alleviated ΔΨm depolarization and mitochondria Ca2+ overload, but it also inhibited the release of cytochrome-c from mitochondria. Subsequently, cytochrome-c release into the cytosol activated the procaspase-9, thereby magnifying downstream caspases cascades such as caspase-3, and leading to nuclear DNA degradation and formation of apoptotic bodies [9, 39] . In our study, geniposide pretreatment remarkably reduced both the protein and mRNA expressions of caspase-3 and Bcl-2. Taken together, these results suggested that geniposide pretreatment protected H9c2 cells against H/R-caused injury through Bcl-2/ Bax/mitochondria apoptotic pathways. GLP-1, a gut hormone, and GLP-1 analogs have beneficial effects on cardiovascular system by inhibiting cardiomyocyte apoptosis during I/R [23, [40] [41] [42] [43] . It has been reported that geniposide, as a novel GLP-1R agonist, exerts different protective effects by activating GLP-1R in various tissues [15] [16] [17] [18] [19] . GLP-1R is expressed in various tissues and organs, including the pancreas, gastrointestinal tract, nervous system, blood vessels, and heart [44, 45] .. Activated GLP-1R mediates the cAMP/ protein kinase A (PKA)/ cAMP-responsive element binding protein (CREB) pathway, resulting in the activation of phosphatidylinositol-3 kinase (PI3K), AKT-protein kinase B (AKT/PKB), and extracellular regulated kinase (ERK1/2) signaling pathway [32, 46] . Accumulating evidence has revealed that AKT activation plays a crucial role in the cardioprotective effect after ischemia-reperfusion injury. Activation of the anti-apoptotic signaling pathway PI3K/AKT could regulate Bcl-2, inhibit caspase cascade activation and reduce death gene expression [32] . In our study, the improvement of cell viability and attenuation of cell apoptosis ratio by geniposide pretreatment during H/R were blocked by exendin (9-39) and LY294002 to some extent. Furthermore, the effects of geniposide pretreatment on decreasing cleaved-caspase-3 protein expression and augmenting p-AKT serine473 /Total-AKT ratio during H/R were also reversed by exendin (9-39) and LY294002. Our experimental results indicated that the underlying mechanisms of the cardioprotective effects of geniposide pretreatment during H/R involved the activation GLP-1R and downstream of PI3K/AKT signaling pathways.
Based on the above results, we concluded that geniposide pretreatment could decrease cardiomyocyte apoptosis during H/R injury. The underlying mechanisms might be the activation of GLP-1R and downstream of PI3K/AKT signaling pathways. Therefore, geniposide may useful as novel therapeutic drug for ischemic heart disease.
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